SeLux Diagnostics

United States
Redfield, Iowa, United States, 02129

Company profile

SeLux Diagnostics company profile

SeLux Diagnostics is a developer of the next-generation phenotyping platform that provides personalized antimicrobial therapies to patients. The company is revolutionizing patient care by expediting the selection of personalized antimicrobial therapy for all infectious disease patients. This advancement will save lives, reduce hospital stays, and address the escalating antibiotic resistance epidemic by minimizing the overuse of broad-spectrum agents.

Business identity

Contact email
[email protected]
Phone number
617-945-9383
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
02129
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
10
Total equity funding
$155.5M
Last funding
Series D / $48M / 2024-04-01
Last equity funding
Series D / $48M
Investors
7
Lead investors
6
Founders
2
Articles
46

Founders and investors

Founders

Aleksandar VacicEric Stern

Lead investors

Biomedical Advanced Research and Development Authority (BARDA)National Institutes of HealthNorthpond VenturesOxford Finance LLCRA Capital ManagementSands Capital Ventures

Investors

National Institutes of HealthNorthpond VenturesOxford Finance LLCRA Capital ManagementSands Capital Ventures